{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T14:59:36Z","timestamp":1753887576257,"version":"3.41.2"},"reference-count":64,"publisher":"Radcliffe Medical Media Ltd","license":[{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/legalcode"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["US Cardiol"],"abstract":"<jats:p>Cardiogenic shock complicating acute MI carries high mortality and morbidity in many cases. Mechanical circulatory support devices are often used in these cases, aimed at improving patient-centered outcomes, although there is a lack of large randomized clinical trial-based evidence for many of such devices. Various circulatory support devices are available with their associated risks and benefits. Ideal circulatory support device intends to unload the myocardium, halt the spiral of ischemia, provide support for revascularization, and\/or allow time for myocardial recovery. In this review paper, the commonly used mechanical circulatory support devices available for use in acute myocardial infarction settings are discussed, and the pros and cons of these devices are examined, considering the contemporary data for each. While this is an evolving field, the authors believe this paper can be helpful to review the current status of the use of mechanical support devices in the setting of acute MI and highlight some of the unmet needs in this field.<\/jats:p>","DOI":"10.15420\/usc.2022.32","type":"journal-article","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T14:00:44Z","timestamp":1683122444000},"source":"Crossref","is-referenced-by-count":0,"title":["Role of Mechanical Circulatory Support in Acute MI Management"],"prefix":"10.15420","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3976-2603","authenticated-orcid":false,"given":"Sundeep","family":"Kumar","sequence":"first","affiliation":[{"name":"University Hospitals Harrington Heart & Vascular Institute, Case Western Reserve University School of Medicine, Cleveland, OH; Case Western Reserve University School of Medicine, Cleveland, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafey","family":"Feroze","sequence":"additional","affiliation":[{"name":"University Hospitals Harrington Heart & Vascular Institute, Case Western Reserve University School of Medicine, Cleveland, OH; Case Western Reserve University School of Medicine, Cleveland, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3281-4442","authenticated-orcid":false,"given":"Farshad","family":"Forouzandeh","sequence":"additional","affiliation":[{"name":"University Hospitals Harrington Heart & Vascular Institute, Case Western Reserve University School of Medicine, Cleveland, OH; Case Western Reserve University School of Medicine, Cleveland, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6096","published-online":{"date-parts":[[2023,4,28]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"McNamara RL, Kennedy KF, Cohen DJ, et al. Predicting in-hospital mortality in patients with acute myocardial infarction. J Am Coll Cardiol 2016;68:626\u201335. https:\/\/doi.org\/10.1016\/j.jacc.2016.05.049; PMID: 27491907.","DOI":"10.1016\/j.jacc.2016.05.049"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Kim MC, Hyun JY, Ahn Y, et al. Optimal revascularization strategy in non-ST-segment-elevation myocardial infarction with multivessel coronary artery disease: culprit-only versus one-stage versus multistage revascularization. J Am Heart Assoc 2020;9:e016575. https:\/\/doi.org\/10.1161\/JAHA.120.016575; PMID: 32750302.","DOI":"10.1161\/jaha.120.016575"},{"key":"ref2","unstructured":"Mehta SR, Wood DA, Storey RF, et al. Complete revascularization with multivessel PCI for myocardial infarction. N Engl J Med 2019;381:1411\u201321. https:\/\/doi.org\/10.1056\/NEJMoa1907775; PMID: 31475795."},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Thiele H, Akin I, Sandri M, et al. PCI strategies in patients with acute myocardial infarction and cardiogenic shock. N Engl J Med 2017;377:2419\u201332. https:\/\/doi.org\/10.1056\/NEJMoa1710261; PMID: 29083953.","DOI":"10.1056\/NEJMoa1710261"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Baran DA, Grines CL, Bailey S, et al. SCAI clinical expert consensus statement on the classification of cardiogenic shock: this document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019. Catheter Cardiovasc Interv 2019;94:29\u201337. https:\/\/doi.org\/10.1002\/ccd.28329; PMID: 31104355.","DOI":"10.1002\/ccd.28329"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Hochman JS, Buller CE, Sleeper LA, et al. Cardiogenic shock complicating acute myocardial infarction--etiologies, management and outcome: a report from the SHOCK Trial Registry. J Am Coll Cardiol 2000;36(Suppl A):1063\u201370. https:\/\/doi.org\/10.1016\/s0735-1097(00)00879-2; PMID:\u00a010985706.","DOI":"10.1016\/s0735-1097(00)00879-2"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Dhruva SS, Ross JS, Mortazavi BJ, et al. Association of use of an intravascular microaxial left ventricular assist device vs intra-aortic balloon pump with in-hospital mortality and major bleeding among patients with acute myocardial infarction complicated by cardiogenic shock. JAMA 2020;323:734\u201345. https:\/\/doi.org\/10.1001\/jama.2020.0254; PMID: 32040163.","DOI":"10.1001\/jama.2020.0254"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Strom JB, Zhao Y, Shen C, et al. Hospital variation in the utilization of short-term nondurable mechanical circulatory support in myocardial infarction complicated by cardiogenic shock. Circ Cardiovasc Interv 2019;12:e007270. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.118.007270; PMID:\u00a030608880.","DOI":"10.1161\/circinterventions.118.007270"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"White JM, Ruygrok PN. Intra-aortic balloon counterpulsation in contemporary practice - where are we? Heart Lung Circ 2015;24:335\u201341. https:\/\/doi.org\/10.1016\/j.hlc.2014.12.003; PMID: 25616681.","DOI":"10.1016\/j.hlc.2014.12.003"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Romeo F, Acconcia MC, Sergi D, et al. The outcome of intra-aortic balloon pump support in acute myocardial infarction complicated by cardiogenic shock according to the type of revascularization: a comprehensive meta-analysis. Am Heart J 2013;165:679\u201392. https:\/\/doi.org\/10.1016\/j.ahj.2013.02.020; PMID: 23622904.","DOI":"10.1016\/j.ahj.2013.02.020"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Kantrowitz A, Tjonneland S, Freed PS, et al. Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. JAMA 1968;203:113\u20138. https:\/\/doi.org\/10.1001\/jama.1968.03140020041011; PMID: 5694059.","DOI":"10.1001\/jama.1968.03140020041011"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Cohen M, Urban P, Christenson JT, et al. Intra-aortic balloon counterpulsation in US and non-US centres: results of the Benchmark Registry. Eur Heart J 2003;24:1763\u201370. https:\/\/doi.org\/10.1016\/j.ehj.2003.07.002; PMID: 14522572.","DOI":"10.1016\/j.ehj.2003.07.002"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Rihal CS, Naidu SS, Givertz MM, et al. 2015 SCAI\/ACC\/HFSA\/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care: Endorsed by the American Heart Association, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation of Value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d\u2019intervention. J Am Coll Cardiol 2015;65:e7\u2013e26. https:\/\/doi.org\/10.1016\/j.jacc.2015.03.036; PMID:\u00a025861963.","DOI":"10.1016\/j.cardfail.2015.03.002"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Mueller H, Ayres SM, Conklin EF, et al. The effects of intra-aortic counterpulsation on cardiac performance and metabolism in shock associated with acute myocardial infarction. J Clin Invest 1971;50:1885\u2013900. https:\/\/doi.org\/10.1172\/JCI106681; PMID: 5564396.","DOI":"10.1172\/jci106681"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Scheidt S, Wilner G, Mueller H, et al. Intra-aortic balloon counterpulsation in cardiogenic shock. Report of a co-operative clinical trial. N Engl J Med 1973;288:979\u201384. https:\/\/doi.org\/10.1056\/NEJM197305102881901; PMID:\u00a04696253.","DOI":"10.1056\/nejm197305102881901"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Shaw J, Taylor DR, Pitt B. Effects of intraaortic balloon counterpulsation on regional coronary blood flow in experimental myocardial infarction. Am J Cardiol 1974;34:552\u20136. https:\/\/doi.org\/10.1016\/0002-9149(74)90126-x; PMID: 4606507.","DOI":"10.1016\/0002-9149(74)90126-x"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Jung C, R\u00f6diger C, Fritzenwanger M, et al. Acute microflow changes after stop and restart of intra-aortic balloon pump in cardiogenic shock. Clin Res Cardiol 2009;98:469\u201375. https:\/\/doi.org\/10.1007\/s00392-009-0018-0; PMID: 19367424.","DOI":"10.1007\/s00392-009-0018-0"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Stone GW, Ohman EM, Miller MF, et al. Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: the benchmark registry. J Am Coll Cardiol 2003;41:1940\u20135. https:\/\/doi.org\/10.1016\/s0735-1097(03)00400-5; PMID:\u00a012798561.","DOI":"10.1016\/s0735-1097(03)00400-5"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Prondzinsky R, Lemm H, Swyter M, et al. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome. Crit Care Med 2010;38:152\u201360. https:\/\/doi.org\/10.1097\/CCM.0b013e3181b78671; PMID:\u00a019770739.","DOI":"10.1097\/ccm.0b013e3181b78671"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Thiele H, Zeymer U, Neumann FJ, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 2012;367:1287\u201396. https:\/\/doi.org\/10.1056\/NEJMoa1208410; PMID: 22920912.","DOI":"10.1056\/nejmoa1208410"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Barron HV, Every NR, Parsons LS, et al. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. Am Heart J 2001;141:933\u20139. https:\/\/doi.org\/10.1067\/mhj.2001.115295; PMID: 11376306.","DOI":"10.1067\/mhj.2001.115295"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Sjauw KD, Engstr\u00f6m AE, Vis MM, et al. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J 2009;30:459\u201368. https:\/\/doi.org\/10.1093\/eurheartj\/ehn602; PMID: 19168529.","DOI":"10.1093\/eurheartj\/ehn602"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Ahmad Y, Sen S, Shun-Shin MJ, et al. Intra-aortic balloon pump therapy for acute myocardial infarction: a meta-analysis. JAMA Intern Med 2015;175:931\u20139. https:\/\/doi.org\/10.1001\/jamainternmed.2015.0569; PMID:\u00a025822657.","DOI":"10.1001\/jamainternmed.2015.0569"},{"key":"ref23","unstructured":"Van de Werf F, Bax J, Betriu A, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. Eur Heart J 2008;29:2909\u201345. https:\/\/doi.org\/10.1093\/eurheartj\/ehn416; PMID:\u00a019004841."},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Kushner FG, Hand M, Smith SC, Jr, et al. 2009 focused updates: ACC\/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC\/AHA\/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2009;54:2205\u201341. https:\/\/doi.org\/10.1016\/j.jacc.2009.10.015; PMID: 19942100.","DOI":"10.1161\/CIRCULATIONAHA.109.192663"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Moulopoulos S, Stamatelopoulos S, Petrou P. Intraaortic balloon assistance in intractable cardiogenic shock. Eur Heart J 1986;7:396\u2013403. https:\/\/doi.org\/10.1093\/oxfordjournals.eurheartj.a062080; PMID: 3732287.","DOI":"10.1093\/oxfordjournals.eurheartj.a062080"},{"key":"ref26","unstructured":"Sanborn TA, Sleeper LA, Bates ER, et al. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol 2000;36(Suppl A):1123\u20139. https:\/\/doi.org\/10.1016\/s0735-1097(00)00875-5; PMID: 10985715."},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Cannon CP, Weintraub WS, Demopoulos LA, et al. Invasive versus conservative strategies in unstable angina and non-Q-wave myocardial infarction following treatment with tirofiban: rationale and study design of the international TACTICS-TIMI 18 Trial. Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy. Thrombolysis in myocardial infarction. Am J Cardiol 1998;82:731\u20136. https:\/\/doi.org\/10.1016\/s0002-9149(98)00540-2; PMID: 9761082.","DOI":"10.1016\/s0002-9149(98)00540-2"},{"key":"ref28","unstructured":"O\u2019Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation 2013;127:e362\u2013425. https:\/\/doi.org\/10.1161\/CIR.0b013e3182742cf6; PMID: 23247304."},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Windecker S, Kolh P, Alfonso F, et al. ESC\/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2014 ESC\/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014;35:2541-619. https:\/\/doi.org\/10.1093\/eurheartj\/ehu278; PMID: 25173339.","DOI":"10.1093\/eurheartj\/ehu278"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Zheng XY, Wang Y, Chen Y, et al. The effectiveness of intra-aortic balloon pump for myocardial infarction in patients with or without cardiogenic shock: a meta-analysis and systematic review. BMC Cardiovasc Disord 2016;16:148. https:\/\/doi.org\/10.1186\/s12872-016-0323-2; PMID: 27391391.","DOI":"10.1186\/s12872-016-0323-2"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Kumbasar SD, Semiz E, Sancaktar O, et al. Concomitant use of intraaortic balloon counterpulsation and streptokinase in acute anterior myocardial infarction. Angiology 1999;50:465\u201371. https:\/\/doi.org\/10.1177\/000331979905000604; PMID:\u00a010378822.","DOI":"10.1177\/000331979905000604"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Ohman EM, Califf RM, George BS, et al. The use of intraaortic balloon pumping as an adjunct to reperfusion therapy in acute myocardial infarction. The thrombolysis and angioplasty in myocardial infarction (TAMI) study group. Am Heart J 1991;121:895\u2013901. https:\/\/doi.org\/10.1016\/0002-8703(91)90205-v; PMID: 1900381.","DOI":"10.1016\/0002-8703(91)90205-v"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"O\u2019Rourke MF, Norris RM, Campbell TJ, et al. Randomized controlled trial of intraaortic balloon counterpulsation in early myocardial infarction with acute heart failure. Am J Cardiol 1981;47:815\u201320. https:\/\/doi.org\/10.1016\/0002-9149(81)90179-x; PMID: 7010976.","DOI":"10.1016\/0002-9149(81)90179-x"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Waksman R, Weiss AT, Gotsman MS, Hasin Y. Intra-aortic balloon counterpulsation improves survival in cardiogenic shock complicating acute myocardial infarction. Eur Heart J 1993;14:71\u20134. https:\/\/doi.org\/10.1093\/eurheartj\/14.1.71; PMID:\u00a08432295.","DOI":"10.1093\/eurheartj\/14.1.71"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Stomel RJ, Rasak M, Bates ER. Treatment strategies for acute myocardial infarction complicated by cardiogenic shock in a community hospital. Chest 1994;105:997\u20131002. https:\/\/doi.org\/10.1378\/chest.105.4.997; PMID: 8162800.","DOI":"10.1378\/chest.105.4.997"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Kovack PJ, Rasak MA, Bates ER, et al. Thrombolysis plus aortic counterpulsation: improved survival in patients who present to community hospitals with cardiogenic shock. J Am Coll Cardiol 1997;29:1454\u20138. https:\/\/doi.org\/10.1016\/s0735-1097(97)82537-5; PMID: 9180104.","DOI":"10.1016\/s0735-1097(97)82537-5"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"van \u2019t Hof AW, Liem AL, de Boer MJ, et al. A randomized comparison of intra-aortic balloon pumping after primary coronary angioplasty in high risk patients with acute myocardial infarction. Eur Heart J 1999;20:659\u201365. https:\/\/doi.org\/10.1053\/euhj.1998.1348; PMID: 10208786.","DOI":"10.1053\/euhj.1998.1348"},{"key":"ref38","unstructured":"Vijayalakshmi K, Kunadian B, Whittaker VJ, et al. Intra-aortic counterpulsation does not improve coronary flow early after PCI in a high-risk group of patients: observations from a randomized trial to explore its mode of action. J Invasive Cardiol 2007;19:339\u201346. PMID: 17712202."},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Patel MR, Smalling RW, Thiele H, et al. Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial. JAMA 2011;306:1329\u201337. https:\/\/doi.org\/10.1001\/jama.2011.1280; PMID: 21878431.","DOI":"10.1001\/jama.2011.1280"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Ohman EM, George BS, White CJ, et al. Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction. Results of a randomized trial. The randomized IABP study group. Circulation 1994;90:792\u20139. https:\/\/doi.org\/10.1161\/01.cir.90.2.792; PMID: 8044950.","DOI":"10.1161\/01.cir.90.2.792"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Gu J, Hu W, Xiao H, et al. Prophylactic intra-aortic balloon pump reduces C-reactive protein levels and early mortality in high-risk patients undergoing percutaneous coronary intervention. Acta Cardiol 2011;66:499\u2013504. https:\/\/doi.org\/10.1080\/ac.66.4.2126599; PMID: 21894807.","DOI":"10.1080\/ac.66.4.2126599"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Sjauw KD, Remmelink M, Baan J, Jr, et al. Left ventricular unloading in acute ST-segment elevation myocardial infarction patients is safe and feasible and provides acute and sustained left ventricular recovery. J Am Coll Cardiol 2008;51:1044\u20136. https:\/\/doi.org\/10.1016\/j.jacc.2007.10.050; PMID: 18325447.","DOI":"10.1016\/j.jacc.2007.10.050"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Meyns B, Stolinski J, Leunens V, et al. Left ventricular support by catheter-mounted axial flow pump reduces infarct size. J Am Coll Cardiol 2003;41:1087\u201395. https:\/\/doi.org\/10.1016\/s0735-1097(03)00084-6; PMID: 12679206.","DOI":"10.1016\/s0735-1097(03)00084-6"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Remmelink M, Sjauw KD, Henriques JP, et al. Effects of mechanical left ventricular unloading by Impella on left ventricular dynamics in high-risk and primary percutaneous coronary intervention patients. Catheter Cardiovasc Interv 2010;75:187\u201394. https:\/\/doi.org\/10.1002\/ccd.22263; PMID:\u00a019941329.","DOI":"10.1002\/ccd.22263"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Ouweneel DM, Eriksen E, Sjauw KD, et al. Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol 2017;69:278\u201387. https:\/\/doi.org\/10.1016\/j.jacc.2016.10.022; PMID: 27810347.","DOI":"10.1016\/j.jacc.2016.10.026"},{"key":"ref46","unstructured":"Schrage B, Ibrahim K, Loehn T, et al. Impella support for acute myocardial infarction complicated by cardiogenic shock. Circulation 2019;139:1249\u201358. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.036614; PMID: 30586755."},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"O\u2019Neill WW, Kleiman NS, Moses J, et al. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. Circulation 2012;126:1717\u201327. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.098194; PMID:\u00a022935569.","DOI":"10.1161\/circulationaha.112.098194"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Esposito ML, Zhang Y, Qiao X, et al. Left ventricular unloading before reperfusion promotes functional recovery after acute myocardial infarction. J Am Coll Cardiol 2018;72:501\u201314. https:\/\/doi.org\/10.1016\/j.jacc.2018.05.034; PMID: 30049311.","DOI":"10.1016\/j.jacc.2018.05.034"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Tarantini G, Masiero G, Burzotta F, et al. Timing of Impella implantation and outcomes in cardiogenic shock or high-risk percutaneous coronary revascularization. Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv 2021;98:E222\u201334. https:\/\/doi.org\/10.1002\/ccd.29674; PMID: 33793051.","DOI":"10.1002\/ccd.29674"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Kapur NK, Alkhouli MA, DeMartini TJ, et al. Unloading the left ventricle before reperfusion in patients with anterior ST-segment-elevation myocardial infarction. Circulation 2019;139:337\u201346. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.038269; PMID: 30586728.","DOI":"10.1161\/CIRCULATIONAHA.118.039462"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Hemradj VV, Karami M, Sjauw KD, et al. Pre-PCI versus immediate post-PCI Impella initiation in acute myocardial infarction complicated by cardiogenic shock. PLOS ONE 2020;15:e0235762. https:\/\/doi.org\/10.1371\/journal.pone.0235762; PMID: 32687502.","DOI":"10.1371\/journal.pone.0235762"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"Basir MB, Kapur NK, Patel K, et al. Improved outcomes associated with the use of shock protocols: updates from the National cardiogenic shock initiative. Catheter Cardiovasc Interv 2019;93:1173\u201383. https:\/\/doi.org\/10.1002\/ccd.28307; PMID: 31025538.","DOI":"10.1002\/ccd.28307"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"Amin AP, Spertus JA, Curtis JP, et al. The evolving landscape of Impella use in the United States among patients undergoing percutaneous coronary intervention with mechanical circulatory support. Circulation 2020;141:273\u201384. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.044007; PMID: 31735078.","DOI":"10.1161\/circulationaha.119.044007"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"Arnaoutakis GJ, Zhao Y, George TJ, et al. Surgical repair of ventricular septal defect after myocardial infarction: outcomes from the Society of Thoracic Surgeons National Database. Ann Thorac Surg 2012;94:436\u201343. https:\/\/doi.org\/10.1016\/j.athoracsur.2012.04.020; PMID: 22626761.","DOI":"10.1016\/j.athoracsur.2012.04.020"},{"key":"ref55","unstructured":"La Torre MW, Centofanti P, Attisani M, et al. Posterior ventricular septal defect in presence of cardiogenic shock: early implantation of the Impella recover LP 5.0 as a bridge to surgery. Tex Heart Inst J 2011;38:42\u20139. PMID: 21423467."},{"key":"ref56","unstructured":"Oman Z, Kumar S, Ghani A, et al. Percutaneous repair of post-myocardial infarction ventricular septal rupture presenting with cardiogenic shock. Am J Cardiovasc Dis 2020;10:376\u201381. PMID: 33224586."},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"Kapur NK, Davila CD, Chweich H. Protecting the vulnerable left ventricle: the art of unloading with VA-ECMO. Circ Heart Fail 2019;12:e006581. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.119.006581; PMID: 31718318.","DOI":"10.1161\/circheartfailure.119.006581"},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"Shibasaki I, Masawa T, Abe S, et al. Benefit of veno-arterial extracorporeal membrane oxygenation combined with Impella (ECpella) therapy in acute coronary syndrome with cardiogenic shock. J Cardiol 2022;80:116\u201324. https:\/\/doi.org\/10.1016\/j.jjcc.2022.02.013; PMID: 35288000.","DOI":"10.1016\/j.jjcc.2022.02.013"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"Kuroki N, Abe D, Iwama T, et al. Association between delay to coronary reperfusion and outcome in patients with acute coronary syndrome undergoing extracorporeal cardiopulmonary resuscitation. Resuscitation 2017;114:1\u20136. https:\/\/doi.org\/10.1016\/j.resuscitation.2017.02.007; PMID: 28215592.","DOI":"10.1016\/j.resuscitation.2017.02.007"},{"key":"ref60","doi-asserted-by":"publisher","unstructured":"Pavasini R, Cirillo C, Campo G, et al. Extracorporeal circulatory support in acute coronary syndromes: a systematic review and meta-analysis. Crit Care Med 2017;45:e1173\u201383. https:\/\/doi.org\/10.1097\/CCM.0000000000002692; PMID: 28841633.","DOI":"10.1097\/ccm.0000000000002692"},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"Thiele H, Lauer B, Hambrecht R, et al. Reversal of cardiogenic shock by percutaneous left atrial-to-femoral arterial bypass assistance. Circulation 2001;104:2917\u201322. https:\/\/doi.org\/10.1161\/hc4901.100361; PMID: 11739306.","DOI":"10.1161\/hc4901.100361"},{"key":"ref62","doi-asserted-by":"publisher","unstructured":"Burkhoff D, Cohen H, Brunckhorst C, et al. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J 2006;152:469.e1\u20138. https:\/\/doi.org\/10.1016\/j.ahj.2006.05.031; PMID: 16923414.","DOI":"10.1016\/j.ahj.2006.05.031"},{"key":"ref63","doi-asserted-by":"publisher","unstructured":"Anderson MB, Goldstein J, Milano C, et al. Benefits of a novel percutaneous ventricular assist device for right heart failure: the prospective RECOVER RIGHT study of the Impella RP device. J Heart Lung Transplant 2015;34:1549\u201360. https:\/\/doi.org\/10.1016\/j.healun.2015.08.018; PMID: 26681124.","DOI":"10.1016\/j.healun.2015.08.018"}],"container-title":["US Cardiology Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.uscjournal.com\/articleindex\/usc.2022.32","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T14:01:23Z","timestamp":1683122483000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.uscjournal.com\/articleindex\/usc.2022.32"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,28]]},"references-count":64,"URL":"https:\/\/doi.org\/10.15420\/usc.2022.32","relation":{},"ISSN":["1758-390X","1758-3896"],"issn-type":[{"type":"electronic","value":"1758-390X"},{"type":"print","value":"1758-3896"}],"subject":[],"published":{"date-parts":[[2023,4,28]]},"article-number":"e04"}}